logo

Cell Therapy Contract Development And Manufacturing Organization Market Share

Statistics for the 2023 & 2024 Cell Therapy Contract Development And Manufacturing Organization market share, created by Mordor Intelligence™ Industry Reports. Cell Therapy Contract Development And Manufacturing Organization share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Health Services Research Cell Therapy Contract Development And Manufacturing Organization Market Market Share

Market Share of Cell Therapy Contract Development And Manufacturing Organization Industry

The market for cell therapy contract development and manufacturing organizations is moderately competitive, with the presence of both small and large players who are involved in strategic activities such as the expansion of services, partnerships, collaborations, as well as mergers, and acquisitions. Catalent Inc., Lonza, Wuxi Biologics, and Recipharm AB are the key players in this market.

Cell Therapy Contract Development And Manufacturing Organization Market Leaders

  1. Catalent Inc

  2. Lonza Group

  3. Recipharm AB

  4. Wuxi Advanced Therapies

  5. Charles River Laboratories International Inc

*Disclaimer: Major Players sorted in no particular order

Cell Therapy Contract Development And Manufacturing Organization Market Concentration

Cell Therapy Contract Development And Manufacturing Organization Market Report Snapshots

Cell Therapy Contract Development and Manufacturing Organization Market Size & Share Analysis - Growth, Trends and Forecasts (2024 - 2029)